CDO1 promoter methylation is associated with gene silencing and is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients

Molecular biomarkers may facilitate the distinction between aggressive and clinically insignificant prostate cancer (PCa), thereby potentially aiding individualized treatment. We analyzed cysteine dioxygenase 1 (CDO1) promoter methylation and mRNA expression in order to evaluate its potential as pro...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Epigenetics
Hoofdauteurs: Meller, Sebastian, Zipfel, Lisa, Gevensleben, Heidrun, Dietrich, Jörn, Ellinger, Jörg, Majores, Michael, Stein, Johannes, Sailer, Verena, Jung, Maria, Kristiansen, Glen, Dietrich, Dimo
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Taylor & Francis 2016
Onderwerpen:
Research Paper
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5193493/
https://ncbi.nlm.nih.gov/pubmed/27689475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15592294.2016.1241931
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items